Cardioprotection by selective SGLT-2 inhibitors in a non-diabetic mouse model of myocardial ischemia/reperfusion injury: a class or a drug effect?
Nikolaou PE, Mylonas N, Makridakis M, Makrecka-Kuka M, Iliou A, Zerikiotis S, Efentakis P, Kampoukos S, Kostomitsopoulos N, Vilskersts R, Ikonomidis I, Lambadiari V, Zuurbier CJ, Latosinska A, Vlahou A, Dimitriadis G, Iliodromitis EK, Andreadou I.
Nikolaou PE, et al. Among authors: zerikiotis s.
Basic Res Cardiol. 2022 May 17;117(1):27. doi: 10.1007/s00395-022-00934-7.
Basic Res Cardiol. 2022.
PMID: 35581445